Skylands Capital’s P3 Health Partners PIII Stock Holding History

Skylands Capital’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-866	Closed	-$339K	–	154
2022 Q1	$339K	Buy	+866	New	+$260K	0.04%	120

Other funds holding PIII

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIP

Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Skylands Capital's PIII Position: Q2 2022 in Review

Skylands Capital sold out of P3 Health Partners (PIII) in Q2 2022, closing a stake of 866 shares — an estimated $339K sold.

Skylands Capital first reported a position in PIII in Q1 2022 and held it in 1 quarter. The position peaked at $339K in Q1 2022. 47 funds tracked by Wall St. Rank hold PIII as of Q2 2022.

Skylands Capital reported no remaining P3 Health Partners position as of Q2 2022 after selling out during the quarter.
Skylands Capital sold 866 P3 Health Partners shares in Q2 2022, an estimated $339K.
Skylands Capital first reported a position in P3 Health Partners in Q1 2022 and held it in 1 quarter.
Skylands Capital's P3 Health Partners position peaked at $339K in Q1 2022.
47 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2022.

Based on Skylands Capital's 13F filing for Q2 2022, filed 28 Jul 2022.